1. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Issue 7 (July 2017) Authors: Vickers, Richard J; Tillotson, Glenn S; Nathan, Richard; Hazan, Sabine; Pullman, John; Lucasti, Christopher; Deck, Kenneth; Yacyshyn, Bruce; Maliakkal, Benedict; Pesant, Yves; Tejura, Bina; Roblin, David; Gerding, Dale N; Wilcox, Mark H; Bhan, Amit; Campbell, Wayne; Chopra, Teena; Deck, Kenneth; ... Journal: Lancet infectious diseases Issue: Volume 17:Issue 7(2017:Jul.) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of ridinilazole compared with vancomycin for the treatment of Clostridium difficile infection: a phase 2, randomised, double-blind, active-controlled, non-inferiority study. Issue 7 (July 2017) Authors: Vickers, Richard J; Tillotson, Glenn S; Nathan, Richard; Hazan, Sabine; Pullman, John; Lucasti, Christopher; Deck, Kenneth; Yacyshyn, Bruce; Maliakkal, Benedict; Pesant, Yves; Tejura, Bina; Roblin, David; Gerding, Dale N; Wilcox, Mark H Journal: Lancet infectious diseases Issue: Volume 17:Issue 7(2017:Jul.) Page Start: 735 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Primary Outcomes From a Phase 3, Randomized, Double-Blind, Active-Controlled Trial of Surotomycin in Subjects With Clostridium difficile Infection. (19th January 2017) Authors: Boix, Vicente; Fedorak, Richard N.; Mullane, Kathleen M.; Pesant, Yves; Stoutenburgh, Uschi; Jin, Mandy; Adedoyin, Adedayo; Chesnel, Laurent; Guris, Dalya; Larson, Kajal B.; Murata, Yoshihiko Journal: Open forum infectious diseases Issue: Volume 4:Number 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗